8-64596656-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_004820.5(CYP7B1):c.1507A>G(p.Lys503Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,612,736 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004820.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP7B1 | NM_004820.5 | c.1507A>G | p.Lys503Glu | missense_variant | Exon 6 of 6 | ENST00000310193.4 | NP_004811.1 | |
CYP7B1 | XM_017014002.2 | c.1573A>G | p.Lys525Glu | missense_variant | Exon 7 of 7 | XP_016869491.1 | ||
CYP7B1 | NM_001324112.2 | c.1234-6812A>G | intron_variant | Intron 5 of 6 | NP_001311041.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 249140Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134942
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460492Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726478
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152244Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74386
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) Computational tools disagree on the variant's effect on normal protein function. -
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Spastic paraplegia Uncertain:1
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 503 of the CYP7B1 protein (p.Lys503Glu). This variant is present in population databases (no rsID available, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CYP7B1-related conditions. ClinVar contains an entry for this variant (Variation ID: 287111). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The c.1507A>G (p.K503E) alteration is located in exon 6 (coding exon 6) of the CYP7B1 gene. This alteration results from a A to G substitution at nucleotide position 1507, causing the lysine (K) at amino acid position 503 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at